SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-22-008584
Filing Date
2022-08-10
Accepted
2022-08-10 16:03:08
Documents
69
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT admp-10q_063022.htm   iXBRL 10-Q 1442908
2 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 9442
3 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 9352
4 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER ex32-1.htm EX-32.1 3663
5 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER ex32-2.htm EX-32.2 3725
  Complete submission text file 0001387131-22-008584.txt   6051342

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT admp-20220630.xsd EX-101.SCH 42432
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT admp-20220630_cal.xml EX-101.CAL 82334
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT admp-20220630_def.xml EX-101.DEF 172489
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT admp-20220630_lab.xml EX-101.LAB 383976
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT admp-20220630_pre.xml EX-101.PRE 299062
63 EXTRACTED XBRL INSTANCE DOCUMENT admp-10q_063022_htm.xml XML 846901
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36242 | Film No.: 221151759
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences